Experiences and challenges of sexual and gender minority patients undergoing breast cancer treatment.
설문조사
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: breast cancer
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Three themes emerged: 1) SGM identity influenced surgical choice, 2) respondents were reluctant to share SGM identity, and 3) appropriate surgical expectations are key to optimize gender-affirming patient-centered outcomes. [CONCLUSION] SGM data is essential to ensure patient-centered surgical decision-making.
[BACKGROUND] This survey study sought to characterize the experiences and treatments of sexual and gender minority (SGM) patients with breast cancer.
APA
Barmettler G, Kohlbeck S, et al. (2026). Experiences and challenges of sexual and gender minority patients undergoing breast cancer treatment.. American journal of surgery, 257, 116947. https://doi.org/10.1016/j.amjsurg.2026.116947
MLA
Barmettler G, et al.. "Experiences and challenges of sexual and gender minority patients undergoing breast cancer treatment.." American journal of surgery, vol. 257, 2026, pp. 116947.
PMID
41950722 ↗
Abstract 한글 요약
[BACKGROUND] This survey study sought to characterize the experiences and treatments of sexual and gender minority (SGM) patients with breast cancer.
[METHODS] The WhySurg survey was modified to focus on SGM patients and distributed via social media, support groups, and clinic flyers between 2023 and 2024. SGM individuals, age ≥18, and a history of breast cancer were eligible. Descriptive and reflexive thematic analyses were performed.
[RESULTS] 50 individuals responded, with 31 (62%) completing it. Most (77%) were cisgender women, 16% nonbinary, and 3% transgender man. Most (58%) were lesbian/gay/homosexual, while 23% were bisexual, 13% pansexual, 13% queer, 3% asexual, 1 heterosexual, and 1 other. 29% experienced discrimination related to their SGM identity during treatment. Three themes emerged: 1) SGM identity influenced surgical choice, 2) respondents were reluctant to share SGM identity, and 3) appropriate surgical expectations are key to optimize gender-affirming patient-centered outcomes.
[CONCLUSION] SGM data is essential to ensure patient-centered surgical decision-making.
[METHODS] The WhySurg survey was modified to focus on SGM patients and distributed via social media, support groups, and clinic flyers between 2023 and 2024. SGM individuals, age ≥18, and a history of breast cancer were eligible. Descriptive and reflexive thematic analyses were performed.
[RESULTS] 50 individuals responded, with 31 (62%) completing it. Most (77%) were cisgender women, 16% nonbinary, and 3% transgender man. Most (58%) were lesbian/gay/homosexual, while 23% were bisexual, 13% pansexual, 13% queer, 3% asexual, 1 heterosexual, and 1 other. 29% experienced discrimination related to their SGM identity during treatment. Three themes emerged: 1) SGM identity influenced surgical choice, 2) respondents were reluctant to share SGM identity, and 3) appropriate surgical expectations are key to optimize gender-affirming patient-centered outcomes.
[CONCLUSION] SGM data is essential to ensure patient-centered surgical decision-making.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- ASO Author Reflections: Identifying Differences in Treatment Patterns in Sexual and Gender Minorities with Breast Cancer.
- Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities.
- ASO Visual Abstract: Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- Overall survival and prognostic factors in young women with breast cancer: a retrospective cohort study from Southern Thailand.
- Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom).
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer.
- Artificial intelligence and breast cancer screening in Serbia: a dual-perspective qualitative study among radiologists and screening-aged women.